Clindamycin Phosphate Gel
NDC Package 46708-623-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Clindamycin Phosphate gel is a medication used to treat acne. This formulation utilizes a gel delivery system. Marketed by Alembic Pharmaceuticals Limited, this product is identified by NDC 46708-623 and is authorized under FDA application ANDA212466.

Identification & Billing

NDC Package Code
46708-623-30
Package Description
1 TUBE in 1 CARTON / 30 g in 1 TUBE
Product Code
11-Digit Billing Format
46708062330
RxNorm Crosswalk
  • RxCUI: 2676585 - clindamycin phosphate 1 % Twice-Daily Topical Gel
  • RxCUI: 2676585 - Twice-Daily clindamycin 0.01 MG/MG Topical Gel
  • RxCUI: 2676585 - clindamycin (as clindamycin phosphate) 1 % Twice-Daily Topical Gel

Clinical Specifications

Proprietary Name
Clindamycin Phosphate
Non-Proprietary Name
Clindamycin Phosphate
Substance Name
Clindamycin Phosphate
Dosage Form
Gel - A semisolid3 dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion.4 A gel may contain suspended particles.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Usage Information
This medication is used to treat acne. It helps to decrease the number of acne lesions. Clindamycin is an antibiotic which works by stopping the growth of bacteria.

Regulatory & Marketing

Labeler Name
Alembic Pharmaceuticals Limited
Product Type
Human Prescription Drug
FDA Application #
ANDA212466
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
04-04-2024
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (46708-623). Click a package code to view its specific billing and regulatory data.

1 TUBE in 1 CARTON / 60 g in 1 TUBE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 46708-623-30 identifies a specific commercial package of 1 tube in 1 carton / 30 g in 1 tube of Clindamycin Phosphate, a human prescription drug labeled by Alembic Pharmaceuticals Limited. This gel is formulated for topical use and contains clindamycin phosphate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Alembic Pharmaceuticals Limited on April 04, 2024. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat acne. It helps to decrease the number of acne lesions. Clindamycin is an antibiotic which works by stopping the growth of bacteria.

How is this Alembic Pharmaceuticals Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 46708062330. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
46708-623-30
11-Digit CMS (5-4-2)
46708-0623-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.